✨ Free AI Report
Bicycle Therapeutics plc: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Bicycle Therapeutics plc
Research Preview

Bicycle Therapeutics plc: Business Overview, Financials & Competitive Analysis

Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a class of medicines for diseases underserved by existing therapeutics in the United States and United Kingdom. The company develops a novel c...

Analyst-debate audio for Bicycle Therapeutics plc

AskCyborg analysts argue the bull and bear cases for Bicycle Therapeutics plc across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Bicycle Therapeutics plc OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
6/ 10Solid

Cyborg Score thesis

Novel Bicycle platform with multiple oncology programs and pharma partnerships offers differentiated approach to hard-to-target...

Read the full analyst-debate transcript →
Industry Biopharmaceutical/Oncology
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 14, 2026
AI-Verified Research
30+ Page Report

Get the Latest Bicycle Therapeutics plc Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Bicycle Therapeutics plc Overview

Pro stress-test →

Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a class of medicines for diseases underserved by existing therapeutics in the United States and United Kingdom. The company develops a novel class of medicines called Bicycles, which are synthetic short peptides constrained to form two loops that stabilize their structural geometry.

Strategic Profile

Pro stress-test →

The company aims to become one of the world's leading solid tumor medicines companies. Bicycle maintains strategic collaborations with major biopharmaceutical companies including Bayer, Novartis, Ionis Pharmaceuticals, and Genentech. Beyond oncology, the company is exploring applications in anti-infective, cardiovascular, ophthalmology, dementia, CNS, neuromuscular and respiratory indications.

Competitive Landscape

Pro stress-test →

Bicycle competes within a crowded oncology biotech landscape with 41 identified competitors including Rhythm Pharmaceuticals and similar clinical-stage biotechs. The company's differentiation lies in its proprietary Bicycle platform technology targeting difficult-to-address tumor antigens.

Industry Context

Bicycle Therapeutics plc operates in Biopharmaceutical/Oncology.

Key facts

Founded: 2009 · Headquarters: Cambridge, UK · Revenue: $19.3M · Market cap: $557M

What the analysts stress-tested

The top findings that survived the multi-agent debate for Bicycle Therapeutics plc.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Bicycle Therapeutics plc has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Rhythm PharmaClinical-stage biotech→ADC PlatformAlternative ADC and immunotherapeutic platforms→Solid Tumor OncologyPrecision oncology and targeted approaches→

Compare Bicycle Therapeutics plc with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Bicycle Therapeutics plc operates in Biopharmaceutical/Oncology. See how the rest of the sector scores on the Cyborg framework.

Top companies in Biopharmaceutical by Cyborg Score

Browse Biopharmaceutical/Oncology research →
NEW · MCP server

Ask your AI assistant about Bicycle Therapeutics plc

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Bicycle Therapeutics plc and its top competitor on Cyborg Score”
“What did Bicycle Therapeutics plc do this quarter?”
“Is Bicycle Therapeutics plc a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Bicycle Therapeutics plc do?+
Bicycle Therapeutics is a clinical-stage pharmaceutical company developing a class of medicines for diseases underserved by existing therapeutics in the United States and United Kingdom. The company develops a novel c...
What is Bicycle Therapeutics plc's Cyborg Score?+
Bicycle Therapeutics plc has a Cyborg Score of 6/10 (Solid). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Bicycle Therapeutics plc's main competitors?+
Named competitors include Rhythm Pharma, ADC Platform, Solid Tumor Oncology. The full competitive landscape is in the AskCyborg report.
How can I get the full Bicycle Therapeutics plc research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Bicycle Therapeutics plc research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Bicycle Therapeutics plc over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More Biopharmaceutical research

Companies in the same sector and named competitors, ranked by Cyborg Score.

9Eli Lilly and Company8argenx SE8Ascendis Pharma A/S8Avidity Biosciences, Inc.8BeOne Medicines AG8Celltrion, Inc.8Corcept Therapeutics Incorporated8Insmed Incorporated8Roivant Sciences Ltd.8Terns Pharmaceuticals, Inc.Top companies in Biopharmaceutical by Cyborg Score